Vygenerované: 14.03.2026 20:52:38
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Dr Reddy's Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer Study New Delhi: Dr According to the disclosure, the Independent Data Monitoring Committee (IDMC) overseeing the TACTI-004 Phase III study recommended discontinuing the trial after conducting a planned interim futility analysis Following the recommendation, enrolment of patients into the study will be halted and Immutep will proceed with an orderly wind-down of the trial.
Doplnenie: Reddy’s Laboratories SA, a wholly owned subsidiary of Dr.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry India's New FTAs to Open Major Opportunities for Pharma, Healthcare Industry: Piyush Goyal New Delhi: The nine free trade agreements (FTAs) finalised by India in the last four years will provide huge business opportunities for the domestic pharma and healthcare sectors, Commerce and Industry Minister Piyush Goyal said on Monday "These agreements open new opportunities for pharmaceuticals, healthcare and medtech sectors," Goyal said in a post-Budget webinar He suggested the industry to focus on taking greater advantage of these pacts and developing a strong healthcare ecosystem.
Doplnenie: "These agreements open new opportunities for pharmaceuticals, healthcare and medtech sectors," Goyal said in a post-Budget webinar.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Pharma Firms Warn LPG Shortage Could Disrupt Life-Saving Drug Production New Delhi: Pharmaceutical companies in Gujarat have expressed concern that a shortage of industrial LPG cylinders could disrupt the production of life-saving medicines, particularly injectable drugs Any interruption in LPG availability can slow down or halt production lines, which may ultimately affect the supply of essential medicines to hospitals and healthcare facilities Industry representatives have urged the state government to ensure uninterrupted LPG supply to prevent any disruption in pharmaceutical manufacturing.
Doplnenie: Any interruption in LPG availability can slow down or halt production lines, which may ultimately affect the supply of essential medicines to hospitals and healthcare facilities.
Súhrn: METHODOLOGY: - Researchers conducted a phase 3 clinical trial (SOLSTICE) to evaluate the efficacy and safety of guselkumab in 451 adult patients with active PsA (three or more swollen and tender joints and C-reactive protein levels ≥ 0 TOPLINE: Guselkumab 100 mg, administered every 4 or 8 weeks, led to significant improvements in signs and symptoms of active psoriatic arthritis (PsA) in patients with inadequate response to only one prior TNF inhibitor and was not associated with any new safety signals 3 mg/dL) who had an inadequate response to only one prior TNF inhibitor.
Doplnenie: - Participants were randomly assigned to receive guselkumab 100 mg every 4 weeks (n = 150), guselkumab 100 mg at weeks 0 and 4 and then every 8 weeks (n = 151), or placebo with crossover to guselkumab every 4 weeks at week 24 (n = 150).
Súhrn: In total, 748 of 5193 consultant psychiatrist posts are unfilled, leaving many patients unable to access vital care and treatment, the college warned The RCPsych Workforce Census 2025 is based on responses from 40 of 48 NHS mental health trusts in England New referrals to mental health services increased from 4.
Doplnenie: Overall, there is one consultant psychiatrist for every 12,700 people in England, according to the census.